# FDA Inspection 1192023 - Xeris Pharmaceuticals, Inc. - November 16, 2022

Source: https://www.globalkeysolutions.net/records/fda_inspections/xeris-pharmaceuticals-inc/753a0c9e-a563-4beb-a87d-7b0775b4650a
Source feed: FDA_Inspections

> FDA Inspection 1192023 for Xeris Pharmaceuticals, Inc. on November 16, 2022. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1192023
- Company Name: Xeris Pharmaceuticals, Inc.
- Inspection Date: 2022-11-16
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1288372 - 2025-07-03](https://www.globalkeysolutions.net/records/fda_inspections/xeris-pharmaceuticals-inc/8ed70653-dffc-4c74-8c8c-bc6ca7388772)
- [FDA Inspection 1086592 - 2019-03-14](https://www.globalkeysolutions.net/records/fda_inspections/xeris-pharmaceuticals-inc/6369c92b-4d9f-4708-84a3-90f803fa2001)

Company: https://www.globalkeysolutions.net/companies/xeris-pharmaceuticals-inc/9cbcaba7-f788-4118-a53e-0134b660ffb5

Office: https://www.globalkeysolutions.net/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c